BIOTECHNOLOGY VALUE FUND L P 13D and 13G filings for MEI Pharma, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
2021-02-11 5:29 pm Sale | 2020-12-31 | 13G | MEI Pharma, Inc. MEIP | BIOTECHNOLOGY VALUE FUND L P | 279,466 4.900% | -64,856![]() (-18.84%) | Filing |